An outbreak of heterogeneous glycopeptide-intermediate Staphylococcus aureus related to a device source in an intensive care unit.

scientific article published on 3 January 2012

An outbreak of heterogeneous glycopeptide-intermediate Staphylococcus aureus related to a device source in an intensive care unit. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/663703
P698PubMed publication ID22227986
P5875ResearchGate publication ID221731868

P50authorEstelle Jumas-BilakQ107216363
P2093author name stringPatrick Chardon
Hélène Jean-Pierre
Sylvie Parer
Anne Lotthé
Rosie Poncet
P2860cites workReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsQ24646677
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureusQ28362193
Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literatureQ31105046
Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to knowQ31704853
Molecular evidence that nasal carriage of Staphylococcus aureus plays a role in respiratory tract infections of critically ill patientsQ33885105
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).Q34691938
Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriersQ34782459
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ34783668
Staphylococcus aureus throat colonization is more frequent than colonization in the anterior naresQ35073211
Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic MethodsQ35541702
Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care centerQ35784453
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections.Q36287998
Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient—importance of low-level resistance to vancomycinQ44420121
Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unitQ44589914
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitalsQ44868572
Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontaminationQ44895623
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinQ45199316
Methicillin-resistant Staphylococcus aureus disease in three communitiesQ46426018
Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical wardQ46810443
A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure.Q53882709
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.Q54070345
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.Q55067143
An Outbreak of Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides in a French General HospitalQ58442608
P433issue2
P921main subjectStaphylococcus aureusQ188121
intensive care unitQ5094647
P304page(s)167-174
P577publication date2012-01-03
P1433published inInfection Control and Hospital EpidemiologyQ6029185
P1476titleAn outbreak of heterogeneous glycopeptide-intermediate Staphylococcus aureus related to a device source in an intensive care unit.
P478volume33

Reverse relations

cites work (P2860)
Q35067853A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012.
Q38023077Computational analysis of interactomes: current and future perspectives for bioinformatics approaches to model the host-pathogen interaction space.
Q35999912Evolving resistance among Gram-positive pathogens
Q98164449Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis
Q36056758Importance of Multifaceted Approaches in Infection Control: A Practical Experience from an Outbreak Investigation
Q38171759Methicillin-resistant Staphylococcus aureus: an evolving pathogen
Q34259874Methicillin-sensitive Staphylococcus aureus CC398 in intensive care unit, France
Q26796560Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates

Search more.